Brokerages Set Mobia Medical, Inc. (NASDAQ:MOBI) Target Price at $20.25

Shares of Mobia Medical, Inc. (NASDAQ:MOBI) have been assigned an average recommendation of “Moderate Buy” from the six research firms that are covering the company, Marketbeat reports. One analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $20.25.

Several equities research analysts have recently commented on MOBI shares. Bank of America started coverage on shares of Mobia Medical in a report on Tuesday, June 2nd. They issued a “buy” rating and a $16.00 price target for the company. BTIG Research started coverage on shares of Mobia Medical in a report on Tuesday, June 2nd. They issued a “buy” rating and a $19.00 price target for the company. Zacks Research upgraded shares of Mobia Medical to a “hold” rating in a report on Wednesday. The Goldman Sachs Group started coverage on shares of Mobia Medical in a report on Tuesday. They issued a “buy” rating and a $31.00 price target for the company. Finally, Wall Street Zen lowered shares of Mobia Medical from a “hold” rating to a “sell” rating in a report on Saturday.

Mobia Medical Price Performance

Mobia Medical stock opened at $12.62 on Tuesday. The stock has a market capitalization of $417.53 million, a price-to-earnings ratio of 66.00 and a beta of 2.84. Mobia Medical has a 1 year low of $10.19 and a 1 year high of $14.77.

Mobia Medical (NASDAQ:MOBI) last posted its quarterly earnings results on Thursday, June 4th. The company reported $999.00 EPS for the quarter. The business had revenue of $12.07 million during the quarter.

Insider Activity

In other news, Director William T. Harrington acquired 533,333 shares of Mobia Medical stock in a transaction that occurred on Monday, May 11th. The stock was purchased at an average price of $15.00 per share, for a total transaction of $7,999,995.00. Following the purchase, the director directly owned 2,006,716 shares in the company, valued at $30,100,740. The trade was a 36.20% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Casey M. Tansey acquired 66,666 shares of Mobia Medical stock in a transaction that occurred on Monday, May 11th. The shares were purchased at an average price of $15.00 per share, with a total value of $999,990.00. Following the purchase, the director owned 233,332 shares in the company, valued at $3,499,980. This represents a 40.00% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have purchased a total of 1,268,332 shares of company stock worth $19,024,980 over the last 90 days.